Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | LMNA | P02545 | 5/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.42 |
| ▸ | MEN1 | O00255 | 5/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 3/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | DRD3 | P35462 | 1/20 | 0.42 |
| ▸ | HTR2B | P41595 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28709952 | 0.98 | MAPT (0.44) | MAPTKDM4EALDH1A1LMNASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL29386046 | 0.98 | MAPT (0.44) | MAPTKDM4EALDH1A1LMNASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL31174158 | 0.98 | MAPT (0.44) | MAPTKDM4EALDH1A1LMNASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL27970719 | 0.98 | MAPT (0.44) | MAPTKDM4EALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL17423265 | 0.91 | ADRA2A (0.51) | MAPTKDM4EALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL24135088 | 0.84 | MAPT (0.38) | MAPTKDM4EALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL12991998 | 0.84 | ATAD2 (0.41) | MAPTKDM4EALDH1A1KMT2AMEN1 | |
| Proflavine SCHEMBL28561176 | 0.83 | LMNA (0.55) | MAPTKDM4EALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL31252243 | 0.81 | MAPT (0.46) | MAPTKDM4EALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL14457625 | 0.81 | DRD3 (0.42) | MAPTKDM4EALDH1A1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2855503-B1 | METHODS FOR USE OF MIXED MULTIFUNCTIONAL SURFACES FOR REDUCING AGGREGATE CONTENT IN PROTEIN PREPARATIONS | AGENCY SCIENCE TECH & RES (SG) | 2019-07-17 | — | — | EP | claimed |
| EP-2855504-B1 | CHROMATOGRAPHIC PURIFICATION OF IMMUNOGLOBULIN G PREPARATIONS WITH PARTICLES HAVING MULTIMODAL FUNCTIONALITIES | AGENCY SCIENCE TECH & RES (SG) | 2018-10-24 | — | — | EP | claimed |
| US-20180201685-A1 | METHODS FOR USE OF MIXED MULTIFUNCTIONAL SURFACES FOR REDUCING AGGREGATE CONTENT IN PROTEIN PREPARATIONS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2018-07-19 | — | — | US | claimed |
| US-9920125-B2 | Methods for use of mixed multifunctional surfaces for reducing aggregate content in protein preparations | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2018-03-20 | — | — | US | claimed |
| US-9890205-B2 | Chromatographic purification of immunoglobulin G preparations with particles having multimodal functionalities | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2018-02-13 | — | — | US | claimed |
| US-20150183852-A1 | CHROMATOGRAPHIC PURIFICATION OF IMMUNOGLOBULIN G PREPARATIONS WITH PARTICLES HAVING MULTIMODAL FUNCTIONALITIES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-07-02 | — | — | US | claimed |
| US-20150183879-A1 | METHODS FOR USE OF MIXED MULTIFUNCTIONAL SURFACES FOR REDUCING AGGREGATE CONTENT IN PROTEIN PREPARATIONS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-07-02 | — | — | US | claimed |
| EP-2855504-A1 | CHROMATOGRAPHIC PURIFICATION OF IMMUNOGLOBULIN G PREPARATIONS WITH PARTICLES HAVING MULTIMODAL FUNCTIONALITIES | Agency For Science, Technology And Research (SG) | 2015-04-08 | — | — | EP | claimed |
| WO-2013180647-A1 | CHROMATOGRAPHIC PURIFICATION OF IMMUNOGLOBULIN G PREPARATIONS WITH PARTICLES HAVING MULTIMODAL FUNCTIONALITIES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2013-12-05 | — | — | WO | claimed |
| EP-1409741-B1 | DETECTION METHOD OF NUCLEIC ACID HYBRIDIZATION | POSCO (KR) | 2006-01-18 | — | — | EP | claimed |
| EP-1409741-A1 | DETECTION METHOD OF NUCLEIC ACID HYBRIDIZATION | Posco (KR) | 2004-04-21 | — | — | EP | claimed |
| WO-2003010338-A1 | DETECTION METHOD OF NUCLEIC ACID HYBRIDIZATION | POSCO (KR) | 2003-02-06 | — | — | WO | claimed |
| EP-0958284-A1 | 9,10-DIHYDROACRIDINE DERIVATIVES POSSESSING ANTIMICROBIAL ACTIVITY | Politechnika Lodzka (PL) | 1999-11-24 | — | — | EP | claimed |
| EP-0252278-B1 | Disinfecting agents and their use in disinfecting the skin and mucous membranes | HENKEL KGAA (DE) | 1998-08-19 | — | — | EP | claimed |
| WO-1998030544-A1 | 9,10-DIHYDROACRIDINE DERIVATIVES POSSESSING ANTIMICROBIAL ACTIVITY | POLITECHNIKA $m(C)ÓDZKA (PL) | 1998-07-16 | — | — | WO | claimed |
| WO-1990014086-A1 | UTILISATION OF ACRIDINE DERIVATIVES IN THE TREATMENT OF RETROVIRAL INFECTIONS IN HUMANS | DEBIOPHARM S.A. (CH) | 1990-11-29 | — | — | WO | claimed |
| US-20260091089-A1 | Pyocyanine Demethylases and related Phenazine Degrading Agents Compositions, Methods and Systems for Interfering with Viability of Bacteria | CALIFORNIA INST OF TECHN (US) | 2026-04-02 | — | — | US | disclosed |
| US-12427188-B2 | Pyocyanine demethylases and related phenazine degrading agents compositions, methods and systems for interfering with viability of bacteria | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2025-09-30 | — | — | US | disclosed |
| EP-0358400-A2 | Improvements in or relating to polymeric compounds | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-03-14 | — | — | EP | disclosed |
| US-4462993-A | REACTION WITH A SUGAR IN PRESENCE OF ACID CATALYST | BIOGAL GYOGYSZERGYAR (HU) | 1984-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12427188-B2 | Pyocyanine demethylases and related phenazine degrading agents compositions, methods and systems for interfering with viability of bacteria | KDM5C, KDM5A, KDM3A | MAPT 3647/4885KDM4E 37/4885ALDH1A1 1384/4885 |
| US-20260091089-A1 | Pyocyanine Demethylases and related Phenazine Degrading Agents Compositions, Methods and Systems for Interfering with Viability of Bacteria | KDM5C, KDM5A, KDM1B | MAPT 4612/4885KDM4E 19/4885ALDH1A1 1630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.